. Author manuscript; available in PMC: 2013 Nov 22.

Published in final edited form as: J Clin Virol. 2011 Mar 9;51(1):10.1016/j.jcv.2011.01.011. doi: 10.1016/j.jcv.2011.01.011

Table 1.

Distribution of the demographic, reproductive, clinical, and STI factors of women with viral load measures at study enrollment.

Variable	Sample (N = 50)	Cleared (n = 21) n (%)	Persisted (n = 29) n (%)	p-value
Mean age (SD)	26.8 (4.6)	37 (3.8)	26.7 (5.2)	p = 0.75
Study site
N (Chiang-Mai)	13	2 (15.4)	11 (84.6)
NE (Khon Kaen)	9	6 (66.7)	3 (33.3)
S (Songhkla-Hat Yai)	14	5 (35.7)	9 (64.3)
C (Bangkok)	14	8 (57.1)	6 (42.9)	p = 0.056
Current contraceptive use
NHC	13	9 (69.2)	4 (30.8)
COC	22	5 (22.7)	17 (77.3)
DMPA	15	7 (46.7)	8 (53.3)	p = 0.024
Duration of COC use^a
<1 year	4	1 (25)	3 (75)
4–5 years	8	3 (37.5)	5 (62.5)
>5 years	10	1 (10)	9 (90)	p = 0.381
Duration of DMPA use^a
<1 year	5	0 (0)	5 (100)
4–5 years	6	4 (66.7)	2 (33.3)
>5 years	4	3 (75)	1 (25)	p = 0.036
Lifetime number of partners
1	24	13 (54.2)	11 (45.8)
2	12	6 (50)	6 (50)
3	2	1 (50)	1 (50)
≥4	12	9 (75)	3 (25)	p = 0.586
Number of recent sexual partners^b
1	38	21 (55.3)	17 (44.7)
>1	12	8 (66.7)	4 (33.3)	p = 0.485
Cytological diagnosis^c
Normal	28	14 (50)	14 (50)
Inflammation	18	6 (33.3)	12(66.7)
AS-CUS	4	1 (25)	3 (75)
≥LSIL	0	0 (0)	0 (0)	p = 0.414
Worst pap diagnosis during follow-up
Normal	17	10 (58.8)	7 (41.2)
Inflammation	26	9 (34)	17 (65.4)
AS-CUS	6	2 (33)	4 (66.7)
LSIL	0	0 (0)	0 (0)
HSIL	1	0 (0)	1 (100)	p = 0.529
STI infection status
Gonorrhea	1	1 (100)	0 (0)	p = 0.235
Chlamydia	9	7 (77.8)	2 (22.2)	p = 0.735
HPV 16 infection type
Prevalent	34	15 (44.1)	19 (55.9)
Incident	16	6 (37.5)	10 (62.5)	p = 0.574

Among COC/DMPA users.

In the last 3 months.

At study enrollment.